Henrik Horndalsveen

  • PhD student; MD
  • +47 22 78 13 83
 

Publications 2023

Langberg CW, Horndalsveen H, Helland Å, Haakensen VD (2023)
Factors associated with failure to start consolidation durvalumab after definitive chemoradiation for locally advanced NSCLC
Front Oncol, 13, 1217424
DOI 10.3389/fonc.2023.1217424, PubMed 37476372

Publications 2022

Gulati G, Tjessem KH, Horndalsveen H, Halvorsen S, Haakensen VD (2022)
[Checkpoint inhibitor-induced myocarditis]
Tidsskr Nor Laegeforen, 142 (18)
DOI 10.4045/tidsskr.21.0817, PubMed 36511752

Horndalsveen H, Alver TN, Dalsgaard AM, Rogg LV, Helbekkmo N, Grønberg BH, Halvorsen TO, Ramberg C, Haakensen VD, Öjlert ÅK, Bjaanaes MM, Helland Å (2022)
Atezolizumab and stereotactic body radiotherapy in patients with advanced non-small cell lung cancer: safety, clinical activity and ctDNA responses-the ComIT-1 trial
Mol Oncol, 17 (3), 487-498
DOI 10.1002/1878-0261.13330, PubMed 36330681

Publications 2021

Haakensen VD, Nowak AK, Ellingsen EB, Farooqi SJ, Bjaanæs MM, Horndalsveen H, Mcculloch T, Grundberg O, Cedres SM, Helland Å (2021)
NIPU: a randomised, open-label, phase II study evaluating nivolumab and ipilimumab combined with UV1 vaccination as second line treatment in patients with malignant mesothelioma
J Transl Med, 19 (1), 232
DOI 10.1186/s12967-021-02905-3, PubMed 34059094

Publications 2017

Vandraas KF, Torfoss D, Berstad AE, Horndalsveen H, Turowski G (2017)
[Cancer patient in his 50's with troublesome palpitations]
Tidsskr Nor Laegeforen, 137 (16)
DOI 10.4045/tidsskr.17.0204, PubMed 28871750

Vandraas KF, Torfoss D, Berstad AE, Horndalsveen H, Turowski G (2017)
Cancer patient in the 50s with troublesome palpitations
Tidsskr. Nor. Laegeforen., 137 (16), 1210-1213

Page visits: 2713